Related Experiment Video
Updated: May 1, 2026

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
IGF-I receptor 275124A>C (rs1464430) polymorphism and athletic performance
Sigal Ben-Zaken1, Yoav Meckel1, Dan Nemet2
1The Zinman College of Physical Education and Sports Sciences at the Wingate Institute, Genetics and Molecular Biology Laboratory, Netanya, Israel.
The Insulin-Like Growth Factor-I receptor (IGF-IR) AA genotype is more common in endurance athletes, potentially benefiting performance. However, this genotype may hinder power athletes, especially at elite levels.
Area of Science:
- Genetics and Sports Science
- Exercise Physiology
- Molecular Biology
Background:
- The Insulin-Like Growth Factor-I receptor (IGF-IR) plays a role in cellular growth and adaptation.
- Specific polymorphisms in the IGF-IR gene, such as the 275124A>C variant, have been linked to exercise-induced cardiac hypertrophy.
- Understanding the prevalence of such genetic variants in different athletic populations can provide insights into performance specializations.
Purpose of the Study:
- To investigate the frequency of the IGF-IR 275124A>C polymorphism (specifically the AA genotype) in elite endurance and power athletes.
- To compare the prevalence of this polymorphism between endurance athletes, power athletes, and non-physically active controls.
- To explore potential associations between the IGF-IR AA genotype and athletic performance levels (elite vs. national).
Main Methods:
- A cohort of 159 athletes (118 men, 41 women) and 68 controls were genotyped for the IGF-IR 275124A>C polymorphism.
- Athletes were categorized into endurance (n=77) and power (n=82) groups based on their sport specialization.
- Participants were further classified as elite or national-level athletes based on competitive achievements.
Main Results:
- The AA genotype was significantly more prevalent in endurance athletes (49%) compared to power athletes (33%), but not different from controls (46%).
- Among endurance athletes, there was no significant difference in AA genotype prevalence between elite and national levels.
- Conversely, elite power athletes showed a significantly lower prevalence of the AA genotype (17%) compared to national-level power athletes (42%).
Conclusions:
- The IGF-IR AA polymorphism may be advantageous for endurance sports, though not directly linked to elite endurance performance.
- The presence of the AA genotype appears to be a potential disadvantage for power athletes, particularly at the elite level.
- IGF-IR polymorphism may help distinguish between athletes at the endurance and power ends of the performance spectrum.
More Related Videos
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
05:48Removal of an Internal Translational Start Site from mRNA While Retaining Expression of the Full-Length Protein
Published on: March 16, 2022
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Principles of Pharmacogenetics: Types of Genetic Variants
Incomplete Dominance
Activation and Inactivation of G Proteins